相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Human total clearance values and volumes of distribution of typical human cytochrome P450 2C9/19 substrates predicted by single-species allometric scaling using pharmacokinetic data sets from common marmosets genotyped for P450 2C19
Shogo Matsumoto et al.
XENOBIOTICA (2021)
Molecular characterization of functional UDP-glucuronosyltransferases 1A and 2B in common marmosets
Yasuhiro Uno et al.
BIOCHEMICAL PHARMACOLOGY (2020)
UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics-A Comprehensive Pharmacogenomic Study
Paivi Hirvensalo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Predicting the Human Hepatic Clearance of Acidic and Zwitterionic Drugs
David A. Tess et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Advances in selecting appropriate non-rodent species for regulatory toxicology research: Policy, ethical, and experimental considerations
Yong-Wook Son et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Justification for species selection for pharmaceutical toxicity studies
Helen Prior et al.
TOXICOLOGY RESEARCH (2020)
Prediction of human pharmacokinetics of long half-life compounds using chimeric mice with humanised liver
Maki Miyamoto et al.
XENOBIOTICA (2019)
Relevance of Half-Life in Drug Design
Dennis A. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Association with polymorphic marmoset cytochrome P450 2C19 of in vivo hepatic clearances of chirally separated R-omeprazole and S-warfarin using individual marmoset physiologically based pharmacokinetic models
Takashi Kusama et al.
XENOBIOTICA (2018)
A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development under the Metabolites in Safety Testing Regulatory Guidance
Simone Schadt et al.
DRUG METABOLISM AND DISPOSITION (2018)
Approaches of validation of a 2-week combined repeated oral dose toxicity study with plasma micro sampling toxicokinetics (PMS-TK) in common marmosets
Hidemi Mochizuki et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2018)
Evaluation of the Utility of Chimeric Mice with Humanized Livers for the Characterization and Profiling of the Metabolites of a Selective Inhibitor (YM543) of the Sodium-Glucose Cotransporter 2
Naoyuki Nakada
PHARMACEUTICAL RESEARCH (2017)
Comparison of predictability for human pharmacokinetics parameters among monkeys, rats, and chimeric mice with humanised liver
Maki Miyamoto et al.
XENOBIOTICA (2017)
New IVIVE method for the prediction of total human clearance and relative elimination pathway contributions from in vitro hepatocyte and microsome data
Julia Riede et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Individual Differences in Metabolic Clearance of S-Warfarin Efficiently Mediated by Polymorphic Marmoset Cytochrome P450 2C19 in Livers
Shotaro Uehara et al.
DRUG METABOLISM AND DISPOSITION (2016)
OATP and MRP2-mediated hepatic uptake and biliary excretion of eprosartan in rat and human
Pengyuan Sun et al.
PHARMACOLOGICAL REPORTS (2014)
A Perspective on the Prediction of Drug Pharmacokinetics and Disposition in Drug Research and Development
Li Di et al.
DRUG METABOLISM AND DISPOSITION (2013)
Principles of early drug discovery
J. P. Hughes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Cassette Dosing for Pharmacokinetic Screening in Drug Discovery: Comparison of Clearance, Volume of Distribution, Half-Life, Mean Residence Time, and Oral Bioavailability Obtained by Cassette and Discrete Dosing in Rats
Rakesh Nagilla et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 3: Comparative Assessement of Prediction Methods of Human Clearance
Barbara J. Ring et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 2: Comparative Assessment of Prediction Methods of Human Volume of Distribution
Rhys Do Jones et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers
Akihiro Yamada et al.
PHARMACOGENETICS AND GENOMICS (2011)
Overview of the marmoset as a model in nonclinical development of pharmaceutical products
Antonia Orsi et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
Theoretical Versus Empirical Allometry: Facts Behind Theories and Application to Pharmacokinetics
Iftekhar Mahmood
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
The Effect of Wellsolve, a Novel Solubilizing Agent, on the Intestinal Barrier Function and Intestinal Absorption of Griseofulvin in Rats
Khuriah Abdul Hamid et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Prediction of Pharmacokinetic Profile of Valsartan in Humans Based on in vitro Uptake-Transport Data
Agnes Poirier et al.
CHEMISTRY & BIODIVERSITY (2009)
Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches
Natilie A. Hosea et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects
Z. Li et al.
XENOBIOTICA (2009)
Biovalidation of an SPE-HPLC-UV-fluorescence method for the determination of Valsartan and its metabolite valeryl-4-hydroxy-valsartan in human plasma
Gorka Iriarte et al.
JOURNAL OF SEPARATION SCIENCE (2007)
Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans
Wakaba Yamashiro et al.
DRUG METABOLISM AND DISPOSITION (2006)
Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes
A Nakashima et al.
XENOBIOTICA (2005)
Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles
T Wajima et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Evaluation of the marmoset as a model species for drug glucuronidation
MG Soars et al.
XENOBIOTICA (2001)
Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteers
R Zaidenstein et al.
THERAPEUTIC DRUG MONITORING (2001)
The selection of marmoset monkeys (Callithrix jacchus) in pharmaceutical toxicology
D Smith et al.
LABORATORY ANIMALS (2001)
Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients
J Stangier et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2000)
In vitro inhibition screening of human hepatic P450 enzymes by five angiotensin-II receptor antagonists
P Taavitsainen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
分享论文
